Amyloid-based models rely on the use of transgenic animals for the expression of mutations linked to familial forms of AD (fAD) in the causative genes for amyloid precursor protein (APP), presenilin 1 (PS1) and presenilin 2 (PS2). The gene discussed is APP; the disease is familial Alzheimer disease.